Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 34 publications
METTL3 alters capping enzyme expression and its activity on ribosomal proteins.
Journal: Scientific reports
Published: May 20, 2024
The Innate Immune System and the TRAIL-Bcl-XL Axis Mediate a Sex Bias in Lung Cancer and Confer a Therapeutic Vulnerability in Females.
Journal: Cancer research
Published: February 21, 2024
METTL3 alters capping enzyme expression and its activity on ribosomal proteins.
Journal: bioRxiv : the preprint server for biology
Published: December 04, 2023
High-Dose Acetaminophen with Concurrent CYP2E1 Inhibition Has Profound Anticancer Activity without Liver Toxicity.
Journal: The Journal of pharmacology and experimental therapeutics
Published: June 01, 2023
HIF-2α-dependent induction of miR-29a restrains TH1 activity during T cell dependent colitis.
Journal: Nature communications
Published: January 19, 2023
A-to-I edited miR-411-5p targets MET and promotes TKI response in NSCLC-resistant cells.
Journal: Oncogene
Published: August 12, 2022
Endothelial growth factor receptor-mutant lung cancer and post-operative care management: one size does not fit all.
Journal: Annals of translational medicine
Published: January 25, 2021
High dose acetaminophen inhibits STAT3 and has free radical independent anti-cancer stem cell activity.
Journal: Neoplasia (New York, N.Y.)
Published: November 24, 2020
Prospective Observational Study Revealing Early Pulmonary Function Changes Associated With Brigatinib Initiation.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: August 27, 2020
Last Updated: 09/26/2026